May 07, 2015
to Indoco Remedies. Piramal Enterprises Limited (‘PEL’, NSE: PEL, BSE: 500302) today announced that it has signed a definitive agreement to sell its clinical research division known as ‘Piramal Clinical Research (PCR)’
Apr 06, 2015
Piramal Fund Management (“PFM”) has committed INR1,200cr to Omkar Group’s luxury residential development in Worli, Mumbai as project specific debt, in one of the largest single project financing transactions in India
Apr 06, 2015
Piramal Foundation of Education Leadership (PFEL) announces the launch of the District Leadership Development Program (DLDP), which will leverage the experience of the Principal Leadership Training Program (PLDP)
Mar 19, 2015
Piramal Fund Management had announced its intention to enter the construction finance space in Q3 FY15. Today, it announces that has approved 9 construction finance proposals totalling INR1100cr.
Feb 17, 2015
Revenue growth across businesses driving strong profitability In both the quarter and nine-month periods, the company delivered a robust financial performance with significant increase in operating profit and net profit, primarily driven by growth in
Jan 23, 2015
Piramal Enterprises Limited (‘PEL’, NSE: PEL, BSE: 500302) today announced that it is in final stages of discussion with the University of Kentucky for the potential acquisition of Coldstream Laboratories Inc.
Jan 21, 2015
Piramal Enterprises' Pharma Solution division, a global leader in contract development and manufacturing (CDMO), was a big winner in the recent CMO Leadership Awards
Aug 10, 2014
Piramal’s initiative to promote pure drinking water to villagers there by creating a positive impact on their health
Jul 23, 2014
Piramal Fund Management has launched a new fund targeting buying of individual residential units–„Indiareit Apartment Fund' seeks to acquire residential units in Tier 1 markets at a significant discount to prevailing market price